| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/17/2006 | WO2006055734A3 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/17/2006 | WO2005086895A3 Ion channel modulators |
| 08/17/2006 | US20060183918 Beta 2-adrenergic receptor agonists |
| 08/17/2006 | US20060183911 Pyridones useful as inhibitors of kinases |
| 08/17/2006 | US20060183910 Pharmaceutical compositions of 4-amino-2-(3-methyl-2,6-dioxo-piperidin-3-yl)-isoindole-1,3-dione |
| 08/17/2006 | US20060183909 Compositions derived from quinoline and quinoxaline, preparation and use thereof |
| 08/17/2006 | US20060183908 Heterocyclic compounds, methods of making them and their use in therapy |
| 08/17/2006 | US20060183905 Derivatives of 4-(thio-or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 08/17/2006 | US20060183904 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers |
| 08/17/2006 | US20060183902 Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 08/17/2006 | US20060183785 For the treatment of pain; epilepsy, manic depression, bipolar disorder, depression, anxiety and diabetic neuropathy; 5-Methyl-1-[2'-(trifluoromethoxy)-1,1'-biphenyl-3-yl]-1H-pyrazole-3-carboxamide |
| 08/17/2006 | US20060183779 Dabigatran etexilate and its methanesulfonic acid salt |
| 08/17/2006 | US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/17/2006 | US20060183742 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 08/17/2006 | US20060183740 Novel salt form of a dopamine agonist |
| 08/17/2006 | US20060183739 Carbonyl compounds |
| 08/17/2006 | US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/17/2006 | US20060179585 Sulfonamide derviatives of polycyclic dyes used for analytical applications |
| 08/17/2006 | CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | CA2597680A1 Process for preparing 2,3-disubstituted indoles |
| 08/17/2006 | CA2597523A1 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated withcytotoxicity in general and apoptosis in particular |
| 08/16/2006 | EP1690854A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 08/16/2006 | EP1690853A1 W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/16/2006 | EP1689743A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 08/16/2006 | EP1689742A1 Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
| 08/16/2006 | EP1689739A1 Azole-based kinase inhibitors |
| 08/16/2006 | EP1689738A2 Heterocyclic anti-migraine agents |
| 08/16/2006 | EP1689737A1 Beta-lactams for the treatment of cns disorders |
| 08/16/2006 | EP1689729A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 08/16/2006 | EP1689724A1 Quinazolinone compounds as anticancer agents |
| 08/16/2006 | EP1689722A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 08/16/2006 | EP1689721A1 Aminopyrazole derivatives as gsk-3 inhibitors |
| 08/16/2006 | EP1689720A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 08/16/2006 | EP1689719A1 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b) |
| 08/16/2006 | EP1689718A1 1-amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 activity |
| 08/16/2006 | EP1689715A1 Tubulin inhibitors |
| 08/16/2006 | EP1689713A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease |
| 08/16/2006 | EP1689712A1 4-phenylpiperidine derivatives as renin inhibitors |
| 08/16/2006 | EP1689493A1 Calcitonin gene related peptide receptor antagonists |
| 08/16/2006 | EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689403A2 Heteroaryl-hydrazone compounds |
| 08/16/2006 | EP1689394A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 08/16/2006 | EP1689392A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689376A2 Diaryl urea derivatives in the treatment of protein kinase dependent diseases |
| 08/16/2006 | EP1689354A2 Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
| 08/16/2006 | EP1689350A1 Use of osteopontin in dental formulations |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1432702B1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |
| 08/16/2006 | EP1397488B1 Novel compounds for chemiluminescense procedures |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1820008A Substituted quinolin-4-ylamine analogues |
| 08/16/2006 | CN1820003A Pyrrole-2, 5-dithione derivatives as liver X receptor modulators |
| 08/16/2006 | CN1820001A Substituted heterocyclic diarylamine analogues |
| 08/16/2006 | CN1820000A A method for the preparation of enantiomerically pure mirtazapine |
| 08/16/2006 | CN1819829A Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 08/16/2006 | CN1817882A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/16/2006 | CN1817881A Production of stilsarin coarse products |
| 08/16/2006 | CN1817880A 2-bit-substituted quinolone compound and use in pharmacey |
| 08/16/2006 | CN1817860A Asymmetric duplex indole phenylethylene salt compound and high-density recording medium therefor |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269817C Dehalogeno compounds |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269807C Aryl substituted piperazine for curing benign prostatauxe |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269776C Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 08/15/2006 | US7091372 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 08/15/2006 | US7091357 Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091353 Isoindole-imide compounds, compositions, and uses thereof |
| 08/15/2006 | US7091350 Produce powerful, particularly chromatic and bright colorations, in red tones, and which are relatively unselective and are stable to outside factors |
| 08/15/2006 | US7091349 Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091222 4-(1,2-Dimethyl-1H-imidazol-4-ylethynyl)-2-methyl-pyridine compounds; treating chronic neurological disorders |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/15/2006 | US7091218 4-indenone, n-benzyl substituted piperdine compounds; inhibiting acetylcholinesterase to treat Alzheimer-type senile dementia |
| 08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
| 08/15/2006 | US7091211 3-(aryl or heteroaryl)-4-((spiropiperidin-1-yl)alkyl)cyclopentyl compounds and stereisomers, used for prevention of lymphadenopathy associated virus infection, and delaying the onset of aquired immune deficiency syndrome |
| 08/15/2006 | US7091209 Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091202 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators |
| 08/15/2006 | US7091201 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 08/15/2006 | US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
| 08/15/2006 | US7090828 Vitronectin receptor antagonist pharmaceuticals |
| 08/15/2006 | US7090756 Controller for redox system |
| 08/15/2006 | CA2258752C Naphthyridines which affect il-4 and g-csf |
| 08/15/2006 | CA2256309C Amidino protease inhibitors |
| 08/15/2006 | CA2213987C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
| 08/15/2006 | CA2201219C Process for the preparation of substituted pyrimidines |
| 08/10/2006 | WO2006084017A2 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| 08/10/2006 | WO2006084015A2 Raf inhibitor compounds and methods |
| 08/10/2006 | WO2006083760A1 AMINO-PYRIDINES AS INHIBITORS OF β-SECRETASE |
| 08/10/2006 | WO2006083673A2 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
| 08/10/2006 | WO2006083454A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |